Navigation Links
Ajanta Launches World's First Once-A-Day Nimesulide Oral Formulation

The Mumbai-based Ajanta Pharmaceuticals (APL) has launched its once-a-day 200mg controlled release nimesulide brand Nimlodi for arthritis. Nimlodi, which was developed by the Company through new drug delivery system, is the world's first once-a-day nimesulide brand for the treatment of arthritis. Ajanta, which manufactures both Allopathic and Ayurvedic medicines, developed this oral formulation in its fully integrated research and development centre at Kandivali in Mumbai. //

Since the brand received marketing approval from the Drug Controller General of India last month, it has been manufactured at Ajanta's Aurangabad factory. Nimlodi is marketed under the Ethicare division of Ajanta and the Company has already filed a patent application for the product. Nimlodi becomes the second most important product in the Ajanta portfolio after Carofit for which it has a global patent. Currently, the nimesulide market in India is worth Rs. 200 crore.

Ajanta, which has been conducting aggressive research for development of novel oral products and improved formulations, is looking for international partnerships in marketing the product all over the world.


'"/>




Page: 1

Related medicine news :

1. Serum Institute Launches New Tetanus-Diphtheria Vaccine
2. Scottish Health Minister Launches Organ Donor Plan
3. Pfizer Launches Viagra For Lung Disease In UK
4. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
5. PM Launches Healthcare Foundation For India
6. African Union Launches A Programme On Acceleration of HIV Prevention
7. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
8. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
9. The British Medical Journal Launches A Health Website
10. APEC Launches Bird Flu Exercise
11. Melbourne University Launches Plan To Produce More Caring Doctors
Post Your Comments:
(Date:7/25/2008)... DALLAS, July 25 /PRNewswire/ -- BeaconEquity.c...tocks making news today., Investors can view all ...http://BeaconEquity.com/m , Today,s Trade Alerts ...),MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK...daq: ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and...
(Date:7/25/2008)... Expanded Relationship Based on Significant Improv...wswire/ -- MDdatacor, Inc., a leader in health,car...d providers, today,announced it has entered into a...ue to support Wellmark,s Collaboration on Quality(... collaboration between Wellmark and,primary care c...
(Date:7/25/2008)... CARLSBAD, Calif., July 25 /PRNewswire/ -- Auto... registration statement on Form S-1 with the,Secur...osed initial public,offering of shares of its comm...be offered, all of which are expected to be offere...he offering, have not yet been,determined., J.P. ...
(Date:7/25/2008)... Whether you are an Olymp...d Warrior, there are Five Things You Need to Know ...the D.I.S.C. Spine and Sports Center , ...25, 2008 -- America,s premier athletes are heading...onditioning and sacrifice in the hopes of capturin...
Breaking Medicine News(10 mins):Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...genital herpes infections has decreased in the las...chers said this drop is due to changes in sexual b...tion between 1988-1994 and 1999-2004 and found tha...es was down from 21 percent to 17 percent. 'The m...
...onducted by Cancer Research UK finds that many wom...some women seem to genuinely forget to take their ...aking drugs. Difficulty in coping with side effec...s were given as main reasons for quitting the pill...
...e Lundy, who had to bear a miscarriage at an emerg...e launched by the health region to review emergenc... conducting the review and will begin the process ...mplaint after a shortage of beds in the emergency ...
...ch has been published in the journal Nature Neuros...heerful mouse’ might hold the key for treatment of...ined that TREK-1 is a gene that might affect trans...y explained that serotonin is known to play an imp...
Other Medicine News:Health News:A New Breed Of Mice Might Hold The Key For Depression Treatment 2
(Date:7/24/2008)...FirstCall/ -- MacroChem Corporation (OTC,Bulletin ...clinical trial,involving 37 patients who completed... and safety study of EcoNail, a topical antifungal...fungus). The composite,primary efficacy endpoint o...e mycology (negative fungal culture and negative K...
(Date:7/23/2008)...-- Sound Pharmaceuticals (SPI) has filed,an Invest...e clinical,testing of a proprietary formulation of...d hearing loss or ototoxicity. The oral capsule,co...nced stage lung cancer,and head and neck cancer pa... marks the second development program for SPI to e...
(Date:7/23/2008)...wire/ -- InCode BioPharmaceutics, Inc.,an emergin...inical test,results demonstrating the utility of t...f the rare chronic blood disorder paroxysmal noctu...ll be presented at the XXII,International Compleme...008., The only treatment currently available for ...
(Date:7/22/2008)... a multi-center 293-patient European, trial -, ...Symbol: CYT, MONTREAL, July 22 /PRNewswire-FirstC...eader in cryotherapy products to treat cardiac,arr...presented from three,European study centers using ...published earlier today in the Journal of the Amer...
Breaking Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 32008 Social Security Report Offers Dire Warning 15317 12008 Social Security Report Offers Dire Warning 15317 2Core Informatics Completes Successful LIMS Implementation for Progenics Pharmaceuticals 4226 1Cells from the Research Institute of the MUHC on the road to China 15315 1Cells from the Research Institute of the MUHC on the road to China 15315 2Yale study shows weight bias is as prevalent as racial discrimination 15312 1
...lts from analyses,looking at factors contributin...(UC), were presented at Digestive Disease Week,(...by Procter &,Gamble (P&G) Pharmaceuticals, Inc. ... improvement of quality of life for UC,patients ... a class,of agents known as 5-ASAs. A separate s...
...ge of Cardiology,s,Board of Trustees has approved ...arising from his statements that resulted in the,b...rgo on the,COURAGE trial data presented at America...ific Session in March. ,The Board accepted the rec... Committee to issue a letter of censure to and pro...
Other Medicine Technology:Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 2Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 3Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 4Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 5
Features the unique design Labcold rack with high ventillation capability to allow oxygen transfer to the platelets. Six levels of retractable stainless steel trays which can be removed and autoclave
Flatbed Agitator.
...nge of storage capacities. Delrin rollers and glid...oothly, eliminating the need for ball bearings whi...ted drawers with non-slip textured coating provide...,i.Series platelet agitators feature a built-in mo...
Platelet agitator.
Medicine Products: